INTERNATIONAL PATENT: SHANGHAI HELIOSON PHARMACEUTICAL CO., LTD., 上海超阳药业有限公司 FILES APPLICATION FOR "COMPOUND HAVING PROTEIN TYROSINE KINASE BTK-DEGRADING ACTIVITY AND PREPARATION METHOD THEREFOR AND USE THEREOF"

GENEVA, Aug. 10 -- SHANGHAI HELIOSON PHARMACEUTICAL CO., LTD. (Floor 4, Building 5, 2168 Chenhang Road,Minhang District, Shanghai 201114), 上海超阳药业有限公司 (中国上海市闵行区陈行公路2168号5幢4层) filed a patent application (PCT/CN2025/074526) for "COMPOUND HAVING PROTEIN TYROSINE KINASE BTK-DEGRADING ACTIVITY, AND PREPARATION METHOD THEREFOR AND USE THEREOF" on Jan 24, 2025. With publication no. WO/2025/162210, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system...